West Pharmaceutical raises quarterly dividend 18% to $0.26 per share
West Pharmaceutical declared a $0.26 quarterly dividend, up 18% from the prior quarter, its 34th straight annual increase, payable November 18.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
The board of directors of West Pharmaceutical Services, Inc., which describes itself as a global leader in innovative injectable drug administration solutions, approved a fourth-quarter dividend of $0.26 per share on October 19, 2026. That is 18% above the $0.22 per share paid in the previous quarter.
According to the company's release distributed via PRNewswire, this marks the thirty-fourth year in a row the dividend has been increased. The payment is scheduled for November 18, 2026, for holders on the register as of November 11, 2026.
why it matters
For investors this is a routine corporate action, but a long run of annual payout increases tends to draw attention from income-focused holders of S&P 500 stocks. West reported fiscal 2025 net sales of $3.07 billion and operates 26 manufacturing facilities worldwide. The payout alone says little about current operating results, though it signals management's confidence in cash generation.
tags
instruments
sources
- West Declares Quarterly Dividend — TradingView, 19 October 2026 at 22:04 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗